出来高 | 0 |
|
|||||
ニュース | - |
名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Protagenic Therapeutics Inc | PTIXW | NASDAQ | Equity Warrant |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
0.004 |
取引数 | 出来高 | 平均音量 |
---|---|---|
0 | 0 | - |
最終取引 | タイプ | 数量 | 価格 | 通貨 |
---|---|---|---|---|
- | 0 | 0.004 | USD |
企業情報 - Protagenic Therapeutics Inc
時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
---|---|---|---|---|---|---|
17.74k | 4.44M | - | 0 | -5M | -1.13 | - |
Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ニュース - Protagenic Therapeutics
日付 | 時間 | 情報元 | タイトル |
---|---|---|---|
2025/2/15 | 07:06 | Edgar (US Regulatory) | Form SCHEDULE 13G/A - Statement of Beneficial Ownership by.. |
2025/1/30 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
2025/1/10 | 20:04 | Edgar (US Regulatory) | Form 8-K - Current report |
2025/1/10 | 20:02 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2025/1/08 | 01:14 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
2025/1/07 | 07:22 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
2025/1/04 | 07:03 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
2024/12/28 | 06:00 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2024/12/20 | 20:12 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
2024/12/19 | 20:24 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
2024/12/03 | 21:20 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/11/23 | 06:12 | Edgar (US Regulatory) | Form 8-K - Current report |
チャート - Protagenic Therapeutics
期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
---|---|---|---|---|---|---|---|
1週 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
NASDAQ:PTIXW -
What is the current Protagenic Therapeutics Inc share price?
The current share price of Protagenic Therapeutics Inc is US$ 0.004
How many Protagenic Therapeutics Inc shares are in issue?
Protagenic Therapeutics Inc has 4,435,000 shares in issue
What is the market cap of Protagenic Therapeutics Inc?
The market capitalisation of Protagenic Therapeutics Inc is USD 17.74k
What is the 1 year trading range for Protagenic Therapeutics Inc share price?
Protagenic Therapeutics Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Protagenic Therapeutics Inc?
The price to earnings ratio of Protagenic Therapeutics Inc is -0.24
What is the reporting currency for Protagenic Therapeutics Inc?
Protagenic Therapeutics Inc reports financial results in USD
What is the latest annual profit for Protagenic Therapeutics Inc?
The latest annual profit of Protagenic Therapeutics Inc is USD -5M
What is the registered address of Protagenic Therapeutics Inc?
The registered address for Protagenic Therapeutics Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagenic Therapeutics Inc website address?
The website address for Protagenic Therapeutics Inc is www.protagenic.com
Which industry sector does Protagenic Therapeutics Inc operate in?
Protagenic Therapeutics Inc operates in the BOOKS: PUBG, PUBG & PRINTING sector